Pharmaceuticals, Biotechnology and Life Sciences
BROOKLYN, N.Y.–(BUSINESS WIRE)–Brooklyn ImmunoTherapeutics, a biopharmaceutical company focused on exploring the role that cytokine-based therapy can have in treating patients…
First engineered, GMP-grade, cryopreserved, off-the-shelf, bi-specific NK cell therapy to enter human clinical trials targeting CD16 and CD19 in patients…
Five-year follow-up analysis from Phase 1 CA209-004 study provides evidence of long-term survival following discontinuation of treatment in patients with…
HERCULES, Calif.–(BUSINESS WIRE)–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products,…
CATALIS’s public and private partners join forces to make Quebec a global leader in the conduct of early-stage clinical trials.…
More than 34% of survey participants agreed that enhanced point-of-prescribing tools to assist prescriber in identification is the most effective…
Veteran Public Affairs Campaign Executive Rich Masters to Join BIO in New Senior Position WASHINGTON–(BUSINESS WIRE)–BIO President & CEO Jim…
Highlights: 42% investigator-assessed ORR achieved in patients with advanced PEComa – a rare sarcoma with no currently approved therapy First…
-Targeted antibody elicits responses in both FGFR3 wild-type and mutant/fusion patients- -Favorable tolerability and safety profile and prolonged treatment duration-…
Biocom’s 2019 Economic Impact Report Highlights the Steady Growth of the Industry Throughout the State SAN DIEGO–(BUSINESS WIRE)–#BayArea—California’s life science…